CIPLA.NS vs. NVS

Last updated Jun 4, 2026

CIPLA.NS (Cipla Limited) and NVS (Novartis AG) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector. Over the past 10 years, CIPLA.NS returned 12.18%/yr vs 13.76%/yr for NVS. At a 0.01 correlation, their price movements are largely independent.

Performance

CIPLA.NS vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Cipla Limited (CIPLA.NS) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CIPLA.NS is traded in INR, while NVS is traded in USD. To make them comparable, the NVS values have been converted to INR using the latest available exchange rates.

Returns By Period

In the year-to-date period, CIPLA.NS achieves a -9.01% return, which is significantly lower than NVS's 13.71% return. Over the past 10 years, CIPLA.NS has underperformed NVS with an annualized return of 12.18%, while NVS has yielded a comparatively higher 13.76% annualized return.

CIPLA.NS

• 1D: -0.30%
• 1M: 3.01%
• YTD: -9.01%
• 6M: -8.81%
• 1Y: -5.66%
• 3Y*: 13.52%
• 5Y*: 8.57%
• 10Y*: 12.18%

NVS

• 1D: 0.00%
• 1M: -0.59%
• YTD: 13.71%
• 6M: 16.83%
• 1Y: 41.80%
• 3Y*: 23.00%
• 5Y*: 20.25%
• 10Y*: 13.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CIPLA.NS vs. NVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CIPLA.NS Cipla Limited	-9.01%	-0.10%	23.72%	16.77%	14.52%	15.78%	73.26%	-7.42%	-14.21%	7.36%
NVS Novartis AG	13.71%	53.99%	3.05%	16.94%	19.67%	-1.74%	5.94%	16.81%	15.54%	12.00%

Correlation

The correlation between CIPLA.NS and NVS is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.11
Correlation (3Y) Calculated over the trailing 3-year period	-0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.00
Correlation (10Y) Calculated over the trailing 10-year period	0.05
Correlation (All Time) Calculated using the full available price history since Jul 2, 2007	0.01

The correlation between CIPLA.NS and NVS shifts across timeframes, from -0.11 (1 year) to 0.05 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

CIPLA.NS vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CIPLA.NS

CIPLA.NS Risk / Return Rank: 29
CIPLA.NS Sharpe Ratio Rank: 29
CIPLA.NS Sortino Ratio Rank: 24
CIPLA.NS Omega Ratio Rank: 24
CIPLA.NS Calmar Ratio Rank: 34
CIPLA.NS Martin Ratio Rank: 33

NVS

NVS Risk / Return Rank: 75
NVS Sharpe Ratio Rank: 79
NVS Sortino Ratio Rank: 73
NVS Omega Ratio Rank: 71
NVS Calmar Ratio Rank: 76
NVS Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CIPLA.NS vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cipla Limited (CIPLA.NS) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CIPLA.NS	NVS	Difference
Sharpe ratio Return per unit of total volatility	-0.27	2.08	-2.35
Sortino ratio Return per unit of downside risk	-0.26	2.77	-3.04
Omega ratio Gain probability vs. loss probability	0.97	1.35	-0.39
Calmar ratio Return relative to maximum drawdown	-0.20	4.66	-4.86
Martin ratio Return relative to average drawdown	-0.41	11.43	-11.84
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CIPLA.NS vs. NVS - Sharpe Ratio Comparison

The current CIPLA.NS Sharpe Ratio is -0.27, which is lower than the NVS Sharpe Ratio of 2.08. The chart below compares the historical Sharpe Ratios of CIPLA.NS and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CIPLA.NS	NVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.27	2.08	-2.35
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.38	1.10	-0.73
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	0.72	-0.24
Sharpe Ratio (All Time) Calculated using the full available price history	0.04	0.70	-0.67

Drawdowns

CIPLA.NS vs. NVS - Drawdown Comparison

The maximum CIPLA.NS drawdown since its inception was -99.02%, which is greater than NVS's maximum drawdown of -30.13%. Use the drawdown chart below to compare losses from any high point for CIPLA.NS and NVS.

Drawdown Indicators

	CIPLA.NS	NVS	Difference
Max Drawdown Largest peak-to-trough decline	-99.02%	-30.13%	-68.89%
Max Drawdown (1Y) Largest decline over 1 year	-28.32%	-9.01%	-19.31%
Max Drawdown (3Y) Largest decline over 3 years	-28.32%	-18.63%	-9.69%
Max Drawdown (5Y) Largest decline over 5 years	-28.32%	-18.63%	-9.69%
Max Drawdown (10Y) Largest decline over 10 years	-43.40%	-21.18%	-22.22%
Current Drawdown Current decline from peak	-17.34%	-8.25%	-9.09%
Average Drawdown Average peak-to-trough decline	-52.85%	-7.24%	-45.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.74%	3.67%	+10.07%

Volatility

CIPLA.NS vs. NVS - Volatility Comparison

Cipla Limited (CIPLA.NS) has a higher volatility of 9.87% compared to Novartis AG (NVS) at 5.86%. This indicates that CIPLA.NS's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CIPLA.NS	NVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.87%	5.86%	+4.01%
Volatility (6M) Calculated over the trailing 6-month period	16.20%	13.93%	+2.27%
Volatility (1Y) Calculated over the trailing 1-year period	20.79%	20.24%	+0.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.04%	18.42%	+4.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.79%	19.16%	+6.63%

Dividends

CIPLA.NS vs. NVS - Dividend Comparison

CIPLA.NS's dividend yield for the trailing twelve months is around 1.16%, less than NVS's 3.32% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CIPLA.NS Cipla Limited	1.16%	1.06%	0.85%	0.68%	0.46%	0.53%	0.49%	0.63%	0.58%	0.33%	0.35%	0.31%
NVS Novartis AG	3.32%	2.90%	3.84%	3.44%	3.70%	3.86%	3.22%	3.03%	3.47%	3.24%	3.73%	3.10%

Financials

Frequently Asked Questions

Can I hold both CIPLA.NS and NVS in my portfolio?

CIPLA.NS and NVS have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.